Doximity Financial Statements
NYSE: DOCSTechnologyEDP ServicesUSD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
Doximity revenue and earnings
In fiscal 2026, Doximity generated $644.9 million in revenue, up 13.1% from fiscal 2025, its 6th consecutive year of revenue growth. Net income was $196.1 million (-12.2% year over year), for a net margin of 30.4% versus a median of 31.0% in the prior 5 years. Gross margin was 89.1% (down from 90.2%) and operating margin 33.3%.
Diluted earnings per share came in at $0.98, down from $1.11. Over the last 5 fiscal years, DOCS's revenue has grown at a 25.5% compound annual rate.
Summary generated from market data by MetaCap's automated system. Methodology
Doximity income statement (annual)
| Fiscal year (USD) | FY 20262026-03-31 | FY 20252025-03-31 | FY 20242024-03-31 | FY 20232023-03-31 | FY 20222022-03-31 | FY 20212021-03-31 | FY 20202020-03-31 |
|---|---|---|---|---|---|---|---|
| Revenue | 644.86M | 570.40M | 475.42M | 419.05M | 343.55M | 206.90M | 116.39M |
| Revenue growth (YoY) | +13.05% | +19.98% | +13.45% | +21.98% | +66.05% | +77.76% | — |
| Cost of Revenue | 70.33M | 55.87M | 50.67M | 53.49M | 39.79M | 31.20M | 14.90M |
| Gross Profit | 574.54M | 514.52M | 424.75M | 365.56M | 303.76M | 175.70M | 101.49M |
| Operating Expenses | 359.62M | 286.73M | 260.88M | 240.45M | 190.22M | 122.40M | 79.33M |
| Research & Development | 130.70M | 93.04M | 81.98M | 80.19M | 62.35M | 43.87M | 32.44M |
| Selling, General & Admin | 228.91M | 191.38M | 170.96M | 160.27M | 127.88M | 78.53M | 46.89M |
| Operating Income | 214.92M | 227.80M | 163.88M | 125.11M | 113.54M | 53.30M | 22.16M |
| Other Income (Expense) | 35.09M | 35.77M | 21.32M | -146.00K | -448.00K | 4.47M | 1.35M |
| Pretax Income | 250.00M | 263.57M | 185.20M | 133.16M | 114.00M | 57.77M | 23.51M |
| Income Tax | 53.95M | 40.39M | 37.62M | 20.34M | -40.78M | 7.56M | -6.22M |
| Net Income | 196.05M | 223.19M | 147.58M | 112.82M | 154.78M | 50.21M | 29.74M |
| Net Income growth (YoY) | -12.16% | +51.23% | +30.81% | -27.11% | +208.27% | +68.85% | — |
| EPS (Basic) | 1.05 | 1.19 | 0.78 | 0.58 | 0.82 | 0.29 | 0.16 |
| EPS (Diluted) | 0.98 | 1.11 | 0.72 | 0.53 | 0.70 | 0.23 | 0.13 |
| Shares Outstanding (Basic) | 187.01M | 186.84M | 190.17M | 193.18M | 163.48M | 74.34M | 66.76M |
| Shares Outstanding (Diluted) | 199.05M | 201.21M | 205.73M | 213.43M | 191.02M | 95.13M | 81.71M |
| EBITDA | 229.30M | 238.46M | 174.14M | 135.39M | 118.58M | 57.01M | 23.06M |
| Gross Margin | 89.09% | 90.20% | 89.34% | 87.24% | 88.42% | 84.92% | 87.20% |
| Operating Margin | 33.33% | 39.94% | 34.47% | 29.86% | 33.05% | 25.76% | 19.04% |
| Net Margin | 30.40% | 39.13% | 31.04% | 26.92% | 45.05% | 24.27% | 25.55% |
This table shows 7 annual periods of Doximity's income statement, from FY 2026 back to FY 2020, across 19 line items including revenue, cost of revenue, gross profit. Values in USD; B = billions, M = millions. Fiscal periods follow DOCS's reporting calendar. What is a income statement?